期刊文献+

MAGE-1与IL-18共表达DNA疫苗在小鼠体内诱导特异性免疫应答能力的研究 被引量:2

Study of specific immune response on mice induced by a DNA vaccine co-expressing both MAGE-1 and interleukin-18
下载PDF
导出
摘要 目的:观察已构建的pcIL-18-MAGE共表达质粒疫苗接种小鼠所引起的免疫应答情况。方法:质粒大量制备肌注小鼠,每隔10天加强免疫1次,共免疫3次。末次免疫后7天,收集血清及脾细胞,流式细胞术检测小鼠T细胞亚群情况及血清中抗MAGE-1多抗的产生,MTT法检测小鼠CTL杀伤活性。结果:pcIL-18、pcMAGE-1、pcIL-18+pcMAGE-1及pcIL-18-MAGE免疫组CD3+、CD4+、CD8+、CD4+/CD8+及MAGE-1抗体的产生均高于pcDNA3免疫组(P<0.05),且pcIL-18-MAGE共表达免疫组高于pcIL-18+pcMAGE-1共同注射组(P<0.05)。pcIL-18-MAGE免疫组对SMMC-7721的杀伤活性最高。结论:pcIL-18-MAGE共表达基因疫苗接种小鼠与其它实验小鼠相比,可以有效产生更好的特异性免疫应答。 Objective: To observate immunologic response of immunized mice by the vaccine pcIL- 18-MAGE. Methods:Abundant plasraids were extracted and immunized mice, two booster injection were carried out at ten days intervals. Seven days after the third immunization, serum antibody against MAGE-1 and T cell subgroup were detected by FCM, and CTL killing activity were assayed through MTT. Results:About serum antibody against MAGE-1 and T cell subgroup,recombinant plasmids groups were all higher than the vacant plasmid pcDNA3 group(P 〈 0.05),and the coexpression group was higher than the group injected both pcIL-18 and pcMAGE-1 (P 〈 0.05). pcIL-18-MAGE group's killing activity was highest against SMMC-7721. Conclusion:The coexpmssion vaccine pclL-18-MAGE can induce better specific immunological responses on mice compared with other experimental groups.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2008年第7期583-587,共5页 Chinese Journal of Immunology
基金 吉林省科技厅应用基础项目(No20050564) 吉林省卫生厅重点实验室项目 吉林省科技厅项目(No200705449)
关键词 MAGE-1 IL-18 共表达DNA疫苗 免疫应答 MAGE-1 IL-18 Co-expressing DNA vaccine Immune response
  • 相关文献

参考文献15

  • 1van der Bruggen P, Traversari C, Chomez P et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma[J]. Science, 1991 ;254(5038) : 1643-1647.
  • 2Nolte A, Scheffold C, Slotty Jet al. Generation of melanoma specific cytotoxic T lymphocytes for allogeneic immunotherapy [ J ]. J Immunother, 2003 ;26(3) :257-269.
  • 3Nicolas van Baren, Marie-Claude Bonnet, Brigitte Dreno et al. Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells[J]. Clinical Oncology, 2005 ; 23 (35) : 9008-9021.
  • 4Triozzi IL,Aldrich W, Allen K O et al. Phase Ⅰ study of plasmid DNA vaccine encoding MART-1 in patients with resected melanoma at risk for relapse[J]. J Immunother,2005 ;28(4) : 382.
  • 5时阳,杨广民,李首庆,马寅芙,谭岩.MAGE-1与IL-18共表达DNA疫苗的构建与体外表达[J].中国老年学杂志,2007,27(19):1865-1868. 被引量:6
  • 6Cho HI, Kim HJ, Oh ST et al. In vitro induction of careinoembruonic antigen(CEA)-specific cytotocic T lymphocytes by dendritic cells transduced with recombinant adenovieuses[ J ]. Vaccine, 2003; 22 (2) : 224-236.
  • 7Celis E, Tsai V, Crimi C a al. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes[ J]. Proc Natl Acad Sci USA, 1994;91 (6) :2105-2109.
  • 8Toso J F, Oei C, Oshidari F et al. MAGE-1-specific precursor cytotoxic T- lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation [ J]. Cancer Res, 1996 ; 56 ( 1 ) : 16-20.
  • 9Valmori D, Lienard D,Waanders Get al. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients [ J ]. Cancer Res, 1997 ; 57 (4) : 735-741.
  • 10Tanaka F, Hashimoto W, Okamura H et al. Rapid generation of potent and tumor-specific cytotoxic T lymphocyte by interleuk in 18 using dendritic cells and natural killer cells[J]. Cancer Res, 2000; 60: 4838- 4844.

二级参考文献1

共引文献5

同被引文献28

  • 1吉晓滨,苏娟,陈敬贤,谢景华.黑色素瘤抗原在喉癌中的表达及临床评价[J].中华临床医师杂志(电子版),2011,5(24):7271-7276. 被引量:7
  • 2唐瑶云,肖健云,赵素萍,冯永,胡瑾.质粒载体介导CD基因对喉癌细胞的杀伤作用研究(英文)[J].中国耳鼻咽喉颅底外科杂志,2005,11(3):136-140. 被引量:2
  • 3姚德茂,潘承恩,李瑞祥,白东晓,李永利.进展期肿瘤主动特异性免疫治疗的临床研究[J].西安交通大学学报(医学版),2006,27(4):397-399. 被引量:3
  • 4Mou DC, Cai SL, Peng JR, et al. Evaluation of MAGE-1 and MAGE-3 as tumour specific marker to detect blood dissemination of hepatocellular carcinoma cells[J].Br J Cancer, 2002, 86 (1): 110- 116.
  • 5Riley JP, Rosenberg SA, Parkhurst MR. Stimulation of tumor-reactive T lymphocytes using mixtures of synthetic peptides derived from tumor associated antigens with diverse MHC binding affinities [ J ]. J Immu Meth, 2003, 276 (1/2): 103-119.
  • 6Akiyama Y, Maruyama K, Tai S, et al. Novel approach to the characterization of melanoma associated peptide-specific CTL lines from Japanese metastatic melanoma patients[J]. Int J Oncol, 2008, 33 (3): 433-41.
  • 7Baren NV, Bonnet MC, Dreno B, et al. Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T Cells [J]. J Clin Oncoh 2005, 23 (35): 9008-9021.
  • 8Ge W, Li Y, I.i ZS, et al. The antitumor immune responses induced by nanoemulsiomencapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route [J]. Cancer Immunol Immunother, 2009, 58 ( 2 ):201-8.
  • 9Ye J, Chen GS, Son HP, et al. Heat shock protein 70 / MAGE-1 tumor vaccine can enhance the potency of MAGE-1 specific cellular immune responses in vivo [J].Cancer ImmunolImmuother, 2004, 53 (9): 825-829.
  • 10Gao J, Huang S, Li M, et al. GM-CSF surface modified B16. F10 melanoma cell vaccine[J]. Vaccine, 2006, 24 (25):5265-5268.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部